The policy changes came after an announcement by the National Health Commission late Monday that China will downgrade its COVID-19 management from Class A to Class B, starting January 8. The Chinese custom said it will not be necessary to undergo PCR testing after entering the country, howev
China had its most difficult year under Xi's rule as it reeled from his costly zero-Covid policy - from months of overzealous enforcement that crushed the economy and stoked historic public discontent, to a wholesale abandonment so abrupt that left a fragile health system scrambling to cope
"There are mounting concerns in the international community on the ongoing COVID-19 surges in China and the lack of transparent data, including viral genomic sequence data, being reported from the PRC," the officials said, using the initials of the People's Republic of China, according to Re
Several renowned artists, actors, opera singers, film directors, and writers have lost their lives amid a recent surge in Omicron infections in China, according to a report of NTD, a New York-based, global television network.
The measure applies to travellers from mainland China and those who visited it within the past seven days. They are required to take a COVID-19 test upon their arrival in Japan. Those who test positive will be quarantined for seven days. The Kyodo news agency said Japanese Prime Minister
Turkish government which initially accepted Chinese vaccines is now scrutinising its efficacy after learning of China's involvement in data tempering of side effects only to enhance its vaccine sale.
The authorities in Sichuan province conducted an online survey where 158,500 people participated and 63 per cent said their PCR or antigen test results came back positive. The province has a population of approximately 83 million.
China's Zhejiang province, a manufacturing hub is recording around a million new COVID-19 cases in a single day and the situation has sparked concerns among people regarding its impact on supply chains, Nikkei Asia reported.
As covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.